Replies to post #417601 on Amarin Corp Plc (AMRN)

[Jasbg]

alm2, Thanks for a great status of where we are - and I agree all the way.

As I have said elsewhere - the Du ruling were an absolute disaster for Amarin - but at the same time we have to acknowledge that Sarissa and Denner would never have invested in Amarin had the SP been above say $20 - 50 - where It would easy have been if door had not been opened for generics.

Sarissa - Denner have specialized in 'turn around' of undervalued Bio Companies - and you are absolutely right - the first super important fase is getting cost under control.

Where Amarin are right now - there is no room for a CEO living in a manison in Switzerland - making $ 6 million a year.

[Jasbg]

alm2, Did you see the 'Simply Wall ST' analysis:

SWOT Analysis for Amarin
Strength

Currently debt free.

Weakness

No major weaknesses identified for AMRN.

Opportunity

Has sufficient cash runway for more than 3 years based on current free cash flows.

Good value based on P/S ratio and estimated fair value.

Significant insider buying over the past 3 months.

https://finance.yahoo.com/news/investors-undervaluing-amarin-corporation-plc-105824559.html


Actually a rather nice read - thinking ahead 🙂